We are excited to invite you to the 2026 ILTS Consensus Conference, at the Johns Hopkins University Bloomberg Center in Washington, D.C. This 2-day event will bring together over 100 international experts, including transplant surgeons, hepatologists, scientists, educators, and thought leaders, to generate consensus statements on critical issues that will reshape the future of liver transplantation. 

Liver transplantation today faces major challenges: 

• Clinical trials remain hampered by heterogeneity, inconsistent endpoints, and limited long-term tracking. 
• Biomarkers lack robust validation and clear pathways for global clinical implementation. 
• Artificial intelligence holds great promise but is constrained by concerns around data quality, bias, and transparency.  

These challenges are not isolated. The design of trials is key to evaluating patient outcomes, while validated biomarkers and AI serve as the tools to enable patient stratification, risk prediction, improved monitoring, accurate diagnosis, and personalized medicine. Addressing them in a unified, global strategy is essential to advance precision, equity, and innovation in the field. 

By critically evaluating the evidence and establishing shared standards, the worldwide experts at this conference will make a lasting imprint on the future of liver transplantation, moving the field forward with clarity, cohesion, and impact. 

We look forward to welcoming you to Washington, D.C., and to shaping this transformative future together. 

We encourage you to secure your registration early and take advantage of this prestigious networking opportunity.

On behalf of the 2026 ILTS Consensus Conference Organizing Committee, we hope we can count on your support.

Sincerely,